Selecta Biosciences, Inc.
SELBNASDAQHealthcare
$0.88
$-0.08(-8.00%)
Market Cap$135200754
P/E Ratio—
52W High$1.99
52W Low$0.785
Selecta Biosciences, Inc. (SELB) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · SELB · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.80M | $38.91M | $0.00M | $110.78M | $85.08M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $72.38M | $68.74M |
| Gross Profit | $0.00M | $0.00M | $0.00M | $38.40M | $16.34M |
| Gross Margin %(computed) | 0.00% | 0.00% | — | 34.66% | 19.21% |
| Operating Expenses | |||||
| R&D Expenses | $58.03M | $45.10M | $71.84M | $72.38M | $68.74M |
| G&A Expenses | $31.47M | $30.13M | $40.58M | $23.86M | $20.94M |
| Total Operating Expenses | $146.20M | $82.81M | $112.42M | $96.24M | $89.67M |
| Operating Income | $0.00M | $0.00M | ($86.42M) | $14.54M | ($4.60M) |
| Operating Margin %(computed) | 0.00% | 0.00% | — | 13.12% | -5.40% |
| Interest Income | $6.58M | $7.39M | $0.00M | $0.96M | $2.80M |
| Interest Expense | $0.00M | $0.00M | ($2.83M) | $3.03M | $2.84M |
| Income Before Tax | ($139.50M) | ($77.14M) | ($238.71M) | $34.77M | ($9.72M) |
| Income Tax Expense | $9.19M | ($0.29M) | ($19.00M) | ($0.61M) | $15.97M |
| Net Income | ($130.30M) | ($77.42M) | ($219.71M) | $35.38M | ($25.69M) |
| Net Margin %(computed) | — | -198.97% | — | 31.94% | -30.19% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-5.02 | $-0.50 | $-1.42 | $0.24 | $-0.22 |
| Wtd Avg Shares | 25.97M | 155.11M | 154.96M | 144.76M | 114.33M |
| EBITDA | $0.00M | $0.00M | ($240.78M) | $16.16M | ($6.86M) |
| EBITDA Margin %(computed) | 0.00% | 0.00% | — | 14.58% | -8.07% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Selecta Biosciences, Inc. data
About Selecta Biosciences, Inc. (SELB) Income Statement
Selecta Biosciences, Inc. (SELB) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, SELB reported revenue of $0.00B, gross profit of $0.00B (gross margin 0.00%), and net income of ($0.13B) — a net profit margin of -4658.63%.
Frequently asked questions
SELB · 4 questionsSelecta Biosciences, Inc. (SELB) reported revenue of $0.00B for 2025, down 92.8% year-over-year.
SELB revenueSELB salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09